Cargando…

Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14(+)HLA-DR(lo/neg) Cells): The Gateway to Improved Responses

Dendritic cells are an important target in cancer immunotherapy based on their critical role in antigen presentation and response to tumor development. The capacity of dendritic cells to stimulate anti-tumor immunity has led investigators to use these cells to mediate anti-tumor responses in a numbe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laborde, Rebecca R., Lin, Yi, Gustafson, Michael P., Bulur, Peggy A., Dietz, Allan B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983500/ https://www.ncbi.nlm.nih.gov/pubmed/24772111 http://dx.doi.org/10.3389/fimmu.2014.00147

Ejemplares similares

Expression profiling of suppressive monocytes (CD14+HLA-DRlow/neg) in cancer patients
por: Cordes, Stefan F, et al.
Publicado: (2013)

The CD14(+)HLA-DR(lo/neg) Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy
por: Mengos, April E., et al.
Publicado: (2019)

Immune independent crosstalk between lymphoma and myeloid suppressor CD14(+)HLA-DR(low/neg) monocytes mediates chemotherapy resistance
por: Zhang, Zhe (Jenny), et al.
Publicado: (2015)

Increased CTLA-4(+) T cells and an increased ratio of monocytes with loss of class II (CD14(+) HLA-DR(lo/neg)) found in aggressive pediatric sarcoma patients
por: Hingorani, Pooja, et al.
Publicado: (2015)

Elevated frequencies of CD14(+)HLA-DR(lo/neg) MDSCs in COVID-19 patients
por: Xue, GuoHui, et al.
Publicado: (2021)

Expansion of CD10(neg) neutrophils and CD14(+)HLA-DR(neg/low) monocytes driving proinflammatory responses in patients with acute myocardial infarction
por: Fraccarollo, Daniela, et al.
Publicado: (2021)

The CD4+/CD14+HLA-DRlo/neg ratio as a prognostic biomarker in cancer patients
por: Dietz, Allan B, et al.
Publicado: (2013)

Lymphoma monocyte crosstalk via HSP27 to promote immune suppression and chemotherapy resistance
por: Zhang, Zhe, et al.
Publicado: (2014)

Tumor monocyte cross talk promotes lymphoma cell resistance to chemotherapy
por: Zhang, Zhe (Jenny), et al.
Publicado: (2013)

IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/−) monocytes in B-cell non-Hodgkin lymphoma
por: Xiu, B, et al.
Publicado: (2015)

CD19 + CD21(lo/neg) cells are increased in systemic sclerosis-associated interstitial lung disease
por: Wilfong, Erin M., et al.
Publicado: (2021)

Tumor Microenvironment CD14(+) Cells Correlate with Poor Overall Survival in Patients with Early-Stage Lung Adenocarcinoma
por: Schenk, Erin L., et al.
Publicado: (2022)

Monocyte subset distribution and surface expression of HLA-DR and CD14 in patients after cardiopulmonary resuscitation
por: Asmussen, Alexander, et al.
Publicado: (2021)

CCR9-expressing CD14+HLA-DR(hi) blood monocytes promote intestinal inflammation in IBD
por: Linton, Ludvig, et al.
Publicado: (2011)

Carotid artery plaque uptake of (11)C-PK11195 inversely correlates with circulating monocytes and classical CD14(++)CD16(−) monocytes expressing HLA-DR
por: Ammirati, Enrico, et al.
Publicado: (2018)

HLA-DR expression on monocytes is decreased in polytraumatized patients
por: Vester, Helen, et al.
Publicado: (2015)

Endogenous PCSK9 may influence circulating CD45(neg)/CD34(bright) and CD45(neg)/CD34(bright)/CD146(neg) cells in patients with type 2 diabetes mellitus
por: Tripaldi, Romina, et al.
Publicado: (2021)

HLA-DR expression on monocytes and the T-cell subset in septic patients
por: Menestrina, N, et al.
Publicado: (2005)

Firmware Update Using Multiple Gateways in LoRaWAN Networks
por: Charilaou, Christia, et al.
Publicado: (2021)

Improving Energy Efficiency in LoRaWAN Networks with Multiple Gateways
por: Loubany, Ali, et al.
Publicado: (2023)

Emergence of AnnexinV(pos) CD31(neg) CD42b(low/neg) extracellular vesicles in plasma of humans at extreme altitude
por: Utermöhlen, Olaf, et al.
Publicado: (2019)

Monocyte HLA-DR in sepsis: shall we stop following the flow?
por: Monneret, Guillaume, et al.
Publicado: (2014)

HLA-DR Expression on Monocytes and Sepsis Index Are Useful in Predicting Sepsis
por: Quirant-Sánchez, Bibiana, et al.
Publicado: (2023)

Comparison of neutrophil CD64 and monocytic HLA-DR with existing biomarkers for the diagnosis and prognosis of sepsis
por: Pandey, Kshitij, et al.
Publicado: (2021)

LoRaWAN Gateway Placement Model for Dynamic Internet of Things Scenarios
por: Matni, Nagib, et al.
Publicado: (2020)

Enhancing Cyber Security of LoRaWAN Gateways under Adversarial Attacks
por: Mohamed, Ali, et al.
Publicado: (2022)

Mobility of LoRaWAN Gateways for Efficient Environmental Monitoring in Pristine Sites
por: Sobhi, Salma, et al.
Publicado: (2023)

Operating/regenerating the beam screen and the NEG
por: Rossi, A
Publicado: (2003)

Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammation
por: Kim, Oh Yoen, et al.
Publicado: (2010)

Decreased Monocyte HLA-DR Expression in Patients with Sepsis and Acute Kidney Injury
por: Wu, Huang-Pin, et al.
Publicado: (2022)

Monocytic HLA-DR Expression in Immune Responses of Acute Pancreatitis and COVID-19
por: Liu, Shiyu, et al.
Publicado: (2023)

Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis
por: Joshi, Ila, et al.
Publicado: (2023)

Expression of mRNA levels of HLA-DRA in relation to monocyte HLA-DR: a longitudinal sepsis study
por: Cajander, SC, et al.
Publicado: (2015)

Enhancing Extensive and Remote LoRa Deployments through MEC-Powered Drone Gateways
por: Gallego-Madrid, Jorge, et al.
Publicado: (2020)

Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19
por: Alberca, Ricardo Wesley, et al.
Publicado: (2020)

Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells
por: Peyron, Ivan, et al.
Publicado: (2018)

MONOCYTE HLA-DR EXPRESSION AND NEUTROPHIL CD64 EXPRESSION AS BIOMARKERS OF INFECTION IN CRITICALLY ILL NEONATES AND INFANTS
por: Juskewitch, Justin E., et al.
Publicado: (2015)

Standardization of neutrophil CD64 and monocyte HLA-DR measurement and its application in immune monitoring in kidney transplantation
por: Peng, Bo, et al.
Publicado: (2022)

HLA-DR expression on monocytes and systemic inflammation in patients with ruptured abdominal aortic aneurysms
por: Haveman, Jan Willem, et al.
Publicado: (2006)

CIITA promoter polymorphism impairs monocytes HLA-DR expression in patients with septic shock
por: Miatello, Jordi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_92b0mt4ug8pm84ds6da3jvtn8o